Early, Subacute Coronary Stent Thrombosis: A Complication of COVID-19 Infection

Soon after it was discovered in Wuhan, China, in December 2019, coronavirus disease 2019 (COVID-19) blow-out very fast and became a pandemic. The usual presentation is respiratory tract infection, but cardiovascular system involvement is sometimes fatal and also a serious personal and health care bu...

Descripción completa

Detalles Bibliográficos
Autores principales: Tabatabai, Sadeq, Bazargani, Nooshin, Al-Tahmody, Kamaleldin, Alhashmi, Jasem Mohammed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Educational Corner − Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678229/
http://dx.doi.org/10.1159/000520461
_version_ 1784616291511828480
author Tabatabai, Sadeq
Bazargani, Nooshin
Al-Tahmody, Kamaleldin
Alhashmi, Jasem Mohammed
author_facet Tabatabai, Sadeq
Bazargani, Nooshin
Al-Tahmody, Kamaleldin
Alhashmi, Jasem Mohammed
author_sort Tabatabai, Sadeq
collection PubMed
description Soon after it was discovered in Wuhan, China, in December 2019, coronavirus disease 2019 (COVID-19) blow-out very fast and became a pandemic. The usual presentation is respiratory tract infection, but cardiovascular system involvement is sometimes fatal and also a serious personal and health care burden. We report a case of a 57-year-old man who was admitted with anterior wall acute myocardial infarction secondary to early coronary stent thrombosis and associated with COVID-19 infection. He was managed with primary coronary angioplasty and discharged home. Procoagulant and hypercoagulability status associated with severe acute respiratory syndrome coronavirus 2 infection is the most likely culprit. Choosing aggressive antithrombotic agents after coronary angioplasty to prevent stent thrombosis during the COVID-19 pandemic may be the answer but could be challenging.
format Online
Article
Text
id pubmed-8678229
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-86782292021-12-17 Early, Subacute Coronary Stent Thrombosis: A Complication of COVID-19 Infection Tabatabai, Sadeq Bazargani, Nooshin Al-Tahmody, Kamaleldin Alhashmi, Jasem Mohammed Dubai Medical Journal Educational Corner − Case Report Soon after it was discovered in Wuhan, China, in December 2019, coronavirus disease 2019 (COVID-19) blow-out very fast and became a pandemic. The usual presentation is respiratory tract infection, but cardiovascular system involvement is sometimes fatal and also a serious personal and health care burden. We report a case of a 57-year-old man who was admitted with anterior wall acute myocardial infarction secondary to early coronary stent thrombosis and associated with COVID-19 infection. He was managed with primary coronary angioplasty and discharged home. Procoagulant and hypercoagulability status associated with severe acute respiratory syndrome coronavirus 2 infection is the most likely culprit. Choosing aggressive antithrombotic agents after coronary angioplasty to prevent stent thrombosis during the COVID-19 pandemic may be the answer but could be challenging. S. Karger AG 2021-11-26 /pmc/articles/PMC8678229/ http://dx.doi.org/10.1159/000520461 Text en Copyright © 2021 by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
spellingShingle Educational Corner − Case Report
Tabatabai, Sadeq
Bazargani, Nooshin
Al-Tahmody, Kamaleldin
Alhashmi, Jasem Mohammed
Early, Subacute Coronary Stent Thrombosis: A Complication of COVID-19 Infection
title Early, Subacute Coronary Stent Thrombosis: A Complication of COVID-19 Infection
title_full Early, Subacute Coronary Stent Thrombosis: A Complication of COVID-19 Infection
title_fullStr Early, Subacute Coronary Stent Thrombosis: A Complication of COVID-19 Infection
title_full_unstemmed Early, Subacute Coronary Stent Thrombosis: A Complication of COVID-19 Infection
title_short Early, Subacute Coronary Stent Thrombosis: A Complication of COVID-19 Infection
title_sort early, subacute coronary stent thrombosis: a complication of covid-19 infection
topic Educational Corner − Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678229/
http://dx.doi.org/10.1159/000520461
work_keys_str_mv AT tabatabaisadeq earlysubacutecoronarystentthrombosisacomplicationofcovid19infection
AT bazarganinooshin earlysubacutecoronarystentthrombosisacomplicationofcovid19infection
AT altahmodykamaleldin earlysubacutecoronarystentthrombosisacomplicationofcovid19infection
AT alhashmijasemmohammed earlysubacutecoronarystentthrombosisacomplicationofcovid19infection

Ejemplares similares